Status:

COMPLETED

Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea Syndrome

Lead Sponsor:

University Hospital, Grenoble

Collaborating Sponsors:

Fondation de Recherche sur l'Hypertension Artérielle

Conditions:

Refractory Hypertension

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The purpose of the study is to investigate the links between blood pressure (BP), overweight or obesity, and sleep apnea syndrome (SAS), by studying a large cohort of subjects suffering from refractor...

Detailed Description

A number of factors predispose subjects to both hypertension and SAS, including overweight/obesity and hyperinsulinism. The pathogenesis of concomitant overweight/obesity and hypertension is multifact...

Eligibility Criteria

Inclusion

  • Patients of either gender, of between 18 and 70
  • Suffering from refractory hypertension as defined by persistent clinical hypertension (\> 140/90 mm Hg according to two different readings 24 hours apart) despite at least three classes of antihypertensive drugs (including a thiazide diuretic) at appropriate doses.
  • Recruited in the Cardiology Departments of the University Hospitals in Grenoble, Toulouse, Marseille and Poitiers, and in the Mozart Clinic in Paris.
  • Outpatients
  • Patients who have signed the consent form
  • Patients affiliated to or beneficiary of the social security system

Exclusion

  • Failure to fulfil the inclusion criteria
  • Treated SAS, whatever the form of the treatment
  • Disease which might affect BP regulation, including Parkinson's disease, kidney or heart transplantation, dysautonomia, severe heart failure
  • Atrial fibrillation or regular extrasystole (\> 10/minute)
  • Night- or shift-work
  • Pregnant and breast-feeding women
  • Patients under legal guardianship
  • Incarcerated patients or adults protected by the law
  • Hospitalised patients
  • Ongoing participation in another clinical research study

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT00746902

Start Date

June 1 2008

End Date

September 1 2014

Last Update

November 7 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital

Grenoble, France